ECCO 2021
Role of JAKi in IBD: What’s new in 2021?
high5immunology.tv | IBD | ECCO 2021
ECCO 2021
Role of JAKi in IBD: What’s new in 2021?
ECCO 2021
IL23 inhibiton: Efficacy & Safety Updates
ECCO 2021
Comparing the different modes of action in IBD:…
ECCO 2021
Novel agents: Do we need new drugs or just…
ECCO 2021
Imaging: routine care vs. clinical trial setting? The…
ECCO 2021
Artificial Intelligence in IBD ... Even today a part of…
ECCO 2021
What are the therapeutic goals in IBD? Clinical goals…
ECCO 2021
Therapeutic algorithms: How to define? Transfering…
ECCO 2021
AI: The new frontier in endoscopy interpretation
ECCO 2021
AI - Has artificial intelligence reached IBD
ECCO 2021
AI is coming!
ECCO 2021
Classification through AI is coming!
ECCO 2021
Intelligenza artificiale: la nuova frontiera in…
ECCO 2021
Künstliche Intelligenz hilfreich bei Auswertung…
ECCO 2021
AI está llegando!
ECCO 2021
L'intelligence artificielle arrive dans la RCH !
ECCO 2021
New Therapeutic Strategies: STARDUST treat-to-target…
ECCO 2021
SEAVUE - Head-to-head comparison: Applicable for daily…
ECCO 2021
SEAVUE: Early intervention leads to great remission;…
ECCO 2021
SAEVUE: The 1st biologic head-to-head trial in Crohn's…
ECCO 2021
SEAVUE: no difference in remission between ustekinumab…
ECCO 2021
Which treatment for acute/severe UC after steroid…
ECCO 2021
The SEAVUE Trial - will it help us to guide and…
ECCO 2021
SEAVUE: From efficacy to pharmacoeconomic perspectives
ECCO 2021
More JAK inhibitors - same questions!
ECCO 2021
Need for early resection in Crohn's disease is not…
ECCO 2021
Welche Therapiestrategie für welches Therapieziel?
ECCO 2021
Adalimumab vs Ustekinumab: dai risultati di confronto…
ECCO 2021
SEAVUE: Early intervention leads to great remission;…
ECCO 2021
Enfin un seuil avec l'UCEIS !
ECCO 2021
Badanie SEAVUE - czy pomoże nam pozycjonować leki…
ECCO 2021
Leczenie chirurgiczne na bardzo wczesnym etapie choroby…
ECCO 2021
Predictive value of Milan Ultrasound in UC
ECCO 2021
PREdiCCt: Predictive factors associated with fatigue in…
ECCO 2021
Hot topic: Intestinational ultrasound for disease…
ECCO 2021
Towards UCEIS cutoff in UC
ECCO 2021
Liquid biopsy as a novel non-invasive biomarker in IBD
ECCO 2021
Symsptoms and signs assocation - the value of histology
ECCO 2021
VARSITY: Epithelial neutrophils are very important…
ECCO 2021
Liquid biopsy opens exciting window for biomarker…
ECCO 2021
Prädiktiver Wert des Darmultraschalls bei UC
ECCO 2021
PREdiCCt: Fatigue assoziierte prädiktive Faktoren
ECCO 2021
Hot topic: Tarmultralyd til monitorering af Crohn's…
ECCO 2021
Quel traitement d'entretien en cas de colite aiguë…
ECCO 2021
New Therapeutic Treatments in IBD: JAKi
ECCO 2021
IL-12/23 Blockade: Mechanism of action
ECCO 2021
New drugs with signifiicant efficacy: ritlecitinib,…
ECCO 2021
Upadacitinib: Impressive induction data in Ulcerative…
ECCO 2021
Results form phase 3 induction studies with…
ECCO 2021
Upadacitinib significantly effective in UC…
ECCO 2021
IL-23 inhibition with risankizumab effective for…
ECCO 2021
SELECTION updates: no apparent safety concerns for…
ECCO 2021
ADVANCE and MOTIVATE: Risankizumab with fast induction…
ECCO 2021
VIBRATO: Ritlecitinib and brepocitinib both effective.…
ECCO 2021
Neue Daten zu JAK-Inhibitoren
ECCO 2021
Neue Aspekte zu IL-12 und IL-23-Antikörpern
ECCO 2021
New drugs with signifiicant efficacy: ritlecitinib,…
ECCO 2021
Resultaten van de fase 3 inductie studies met…
ECCO 2021
Ritlecitinib und Brepocitinib: Neue Targets der…
ECCO 2021
Anti-IL-23 Antikörper könnten potentielle Game-changer…
ECCO 2021
Providing CLARITY on COVID-19 in IBD
ECCO 2021
5-ASA - back from the other side? New COVID-19 safety…
ECCO 2021
Immune response to anti-SARS-CoV-2 vaccinations in…
ECCO 2021
5-ASA - powrót z zaświatów? Nowe dane z badania…
ECCO 2021
Odpowiedź immunologiczna na szczepienia przeciw…
ECCO 2021
Wide spectrum of treatments for IBD
ECCO 2021
Espectro de tratamientos amplio para IBD?
ECCO 2021
Fecal transplantation or diet for Ulcerative Colitis?
ECCO 2021
Update ECCO-Guideline on Vaccination and Vaccination…
ECCO 2021
Appendectomy for Ulcerative Colitis
ECCO 2021
My perspective on ECCO2021
ECCO 2021
Increasing prevalence of IBD in Brazil
ECCO 2021
CRAFT UC: Diet more effective than FMT? We need more…
ECCO 2021
El ECCO 2021 desde mi punto de vista
ECCO 2021
Konditionierte Diät ist der FMT bei CU überlegen
ECCO 2021
Stoelgangstransplantatie of dieet voor colitis ulcera?
ECCO 2021
Stigende forekomst af IBD i Brasilien
ECCO 2021
Appendektomi ved patienter med colitis ulcerosa
ECCO 2021
Neue ECCO-Leitlinie zu Infektionen und Impstrategie
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend.
Jetzt gleich den Fragebogen ausfüllen!